OMND · Optimind Pharma Corp. · Financials
Market Cap
515,742 CAD
Shares
103.15M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
121.29K
+2.5%
FY2026
Net Income
-117.94K
+45.4%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 |
|---|---|---|
| CAD | 121.29K | 118.37K |
| CAD | -117.94K | -215.81K |
| CAD | -117.94K | -215.81K |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.